- Update on Microbiota-derived therapies for recurrent Clostridioides difficile infections, 20232024 | 2. lékařská fakulta
- Aktualizovaný doporučený postup pro léčbu nemocných s kolitidou vyvolanou Clostridioides difficile2022 | 2. lékařská fakulta, 3. lékařská fakulta
- Mortality following clostridioides difficile infection in Europe: A retrospective multicenter case-control study2021 | 2. lékařská fakulta
- Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view?2022 | 2. lékařská fakulta
- European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults2021 | Publikace bez příslušnosti k fakultě
- How to: Clostridioides difficile infection in children2022 | Publikace bez příslušnosti k fakultě
- Hear My Voice: involving patients in Clostridioides difficile infection research2023 | 2. lékařská fakulta
- Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection2023 | 2. lékařská fakulta
- Infekce vyvolané Clostridioides difficile u dětských pacientů Fakultní nemocnice v Motole2022 | 2. lékařská fakulta
- Re: 'the effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes' by Stabholz et al2024 | 2. lékařská fakulta
- Effect of Restriction of Fluoroquinolone Antibiotics on Clostridioides difficile Infections in the University Hospital Hradec Králové2021 | 3. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Strong Antimicrobial Effects of Xanthohumol and Beta-Acids from Hops against Clostridioides difficile Infection In Vivo +12021 | Lékařská fakulta v Hradci Králové
- Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection-an observational cohort study2021 | 2. lékařská fakulta, 3. lékařská fakulta
- Clostridioides difficile infections were predominantly driven by fluoroquinolone-resistant Clostridioides difficile ribotypes 176 and 001 in Slovakia in 2018-20192023 | 2. lékařská fakulta
- An Outbreak of Clostridium (Clostridioides) difficile Infections within an Acute and Long-Term Care Wards Due to Moxifloxacin-Resistant PCR Ribotype 176 Genotyped as PCR Ribotype 027 by a Commercial Assay2020 | 2. lékařská fakulta
- Heterogeneity in practices to reduce the risk of transmission of Clostridioides difficile in healthcare settings: a survey of ESCMID Study Group for Clostridioides difficile (ESGCD) members2024 | 2. lékařská fakulta
- Clostridium difficile a současné pohledy na léčbu a prevenci2020 | Lékařská fakulta v Hradci Králové
- Current use of fecal microbiota transfer in patients with hematologic diseases: a survey on behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT2023 | Publikace bez příslušnosti k fakultě
- The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients2020 | 2. lékařská fakulta
- 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients2019 | 1. lékařská fakulta
- Fekální mikrobiální terapie - tajemná metoda, nebo východisko budoucích léčebných modulací střevní mikrobioty?2021 | 3. lékařská fakulta
- Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review2022 | 2. lékařská fakulta
- Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study2020 | 2. lékařská fakulta
- Protocol for faecal microbiota transplantation in irritable bowel syndrome: the MISCEAT study - a randomised, double-blind cross-over study using mixed microbiota from healthy donors2022 | 2. lékařská fakulta, 3. lékařská fakulta, Matematicko-fyzikální fakulta